Switching Psychiatric Providers Without Losing Progress

By Jacinta Wangui, DNP, ARNP · Evolving eHealth · Clinically reviewed 7/20/26

Maybe your prescriber retired. Maybe you moved states, your insurance changed, or your visits shrank into a rushed fifteen minutes with someone new each time. Whatever brought you here, transferring psychiatric care feels risky when a medication is finally working — and that instinct is correct. It is also manageable. A good transfer is mostly logistics, started early.

Here is what the evidence says about the actual risk, and the practical steps that protect your progress while you change providers.

The refill gap is the real danger — not the new provider

Most people worry about whether a new prescriber will “get” them. The larger clinical risk is simpler: running out of medication while you search. The ANTLER trial, published in the New England Journal of Medicine, followed 478 primary care patients on long-term antidepressants who were randomized either to continue or to taper off. By 52 weeks, relapse occurred in 56% of those who discontinued versus 39% of those who maintained treatment (hazard ratio 2.06, 95% CI 1.56–2.70) [1].

Two things are worth noticing about that number. First, the discontinuation group tapered under supervision, with clinical support — a genuinely planned stop. An unplanned gap because a prescription ran dry is the same physiological event without any of the planning. Second, relapse was not universal: a substantial share of people stopped without relapsing. This is a risk to manage deliberately, not a reason for alarm.

Discontinuation symptoms are a separate issue from relapse. The largest analysis to date — 79 studies and more than 20,000 patients — estimated that about 15% of people stopping an antidepressant experience discontinuation symptoms directly attributable to stopping (roughly one in six or seven), with severe symptoms in about 3% [2]. Dizziness, headache, nausea, insomnia, and irritability are the common ones, and they are easily mistaken for the original condition returning — which is exactly why an unsupervised gap is a poor time to be interpreting your own symptoms.

The practical takeaway: start your transfer while you still have a two-to-three-week supply. If you are already out, say so when you book so scheduling can reflect it.

Gather three things (and don’t worry about the rest)

A productive first visit needs less documentation than most people assume. Prioritize:

• Your medication list with exact doses — including psychiatric medications, everything else you take, and supplements. A photo of the pharmacy labels works fine.
• Your most recent visit summary or treatment note, if your previous provider’s portal is still accessible. Download it before your account is deactivated.
• Recent labs, if your medication requires monitoring — lithium levels, thyroid and kidney function, metabolic panels for certain antipsychotics.

Missing pieces do not block the visit. With your signed authorization, your new provider can request records directly from the previous one; that just takes longer, so sign the release as early as possible. And your own memory counts as data: what you have tried, what helped, what side effects you refused to live with.

What a good transfer visit actually covers

A transfer evaluation should review more than the contents of your pill bottle. Expect questions about your diagnosis and how it was reached, what has been tried before and why each attempt ended, side effects you have tolerated or rejected, and — the question rushed care skips — whether the current regimen is working as well as you deserve, or merely working well enough that nobody has revisited it.

You should also leave knowing what happens next: when your next follow-up is, which labs are due and when, how refills will be handled, and how to reach the practice between visits. If a provider proposes changing a regimen that is working for you, the reasoning should be explained and the decision should be yours. Continuity is the default; changes are a conversation.

One thing to confirm before you book: controlled medications

If your treatment includes a controlled medication — certain ADHD medications, some anxiety and sleep medications — telehealth prescribing is governed by federal and state rules that vary by medication and by state, and that have changed repeatedly in recent years. A responsible practice will tell you what applies to your situation before you book, not after your first appointment. Ask directly. The answer should be specific.

What a good landing looks like

Six months after a well-run transfer, you should not be re-telling your history from the beginning at every visit. You should have a prescriber who remembers your last appointment and your baseline, refills that arrive without a scramble, labs ordered when they are due, and adjustments that build on what came before instead of restarting from zero. That is stewardship — and it is a reasonable thing to expect from psychiatric medication management.

Transferring your care to Evolving eHealth

Our practice was built for exactly this situation: one board-certified psychiatric nurse practitioner, every visit, for as long as you need us. Your transfer evaluation reviews your diagnosis, current regimen, history, and goals; we request outside records with your permission; and if your medication is working, our job is to keep it working — monitoring, on-time refills, labs when due, and honest options if something could be better.

Book before your refills run low. Most new patients are seen within the week, and telehealth visits are available across all eleven states where we are licensed.

If you are in crisis, do not wait for an appointment. Call or text 988 to reach the Suicide & Crisis Lifeline, available 24/7, or text HOME to 741741. For medical emergencies, call 911.

References

1. Lewis G, Marston L, Duffy L, et al. Maintenance or Discontinuation of Antidepressants in Primary Care (ANTLER trial). N Engl J Med. 2021;385:1257-1267.
2. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry. 2024;11(7):526-535.

This article is for general medical education and does not substitute for an individualized medical evaluation. Never stop or change a psychiatric medication without speaking to a licensed clinician. Individual circumstances and responses vary.